AKASA vs Infinx Patient Access Plus
AKASA vs Infinx Patient Access Plus, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AKASA is on 53/100 and Infinx Patient Access Plus on 54/100.
Where each one leads
AKASA
- agent readiness: 42/100 against 34/100
- domain rating: 63/100 against 50/100
Infinx Patient Access Plus
- headcount: 5,145 against 240
- LinkedIn following: 121,914 against 10,872
At a glance
| Measure | AKASA | Infinx Patient Access Plus |
|---|---|---|
| What it is | AKASA provides AI-powered automation solutions for healthcare operations, focusing on revenue cycle management to reduce costs and improve efficiency. | AI-powered patient access and revenue cycle management solutions for healthcare providers. |
| Category | HealthTech, Revenue Cycle Management, Healthcare Automation, Medical Billing | HealthTech, Healthcare IT, Insurance, Benefits Verification |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2019 | 2012 |
| Headquarters | South San Francisco, United States | Cupertino, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | AKASA | Infinx Patient Access Plus |
|---|---|---|
| Employees | 240 | 5,145 |
| Total funding | $70.0M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 10,872 | 121,914 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AKASA | Infinx Patient Access Plus |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 54/100 |
| Traction | 59/100 | 20/100 |
| Team | Not published | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 22/100 | 30/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 50/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AKASA | Infinx Patient Access Plus |
|---|---|---|
| CMS | Framer | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
| Support stack | Not detected | HubSpot |
AKASA vs Infinx Patient Access Plus: common questions
Which is better, AKASA or Infinx Patient Access Plus?
On our 0-100 score Infinx Patient Access Plus rates higher (54/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do AKASA and Infinx Patient Access Plus compare on the numbers?
AKASA leads on agent readiness (42/100 against 34/100), domain rating (63/100 against 50/100). Infinx Patient Access Plus leads on headcount (5,145 against 240), LinkedIn following (121,914 against 10,872).
Read the full AKASA review and pricing or the Infinx Patient Access Plus review and pricing. You can also browse other AKASA alternatives we track.